Solid Tumors clinical trials
Showing 801–850 of 1,133 active trials. Describe your situation to see which ones look like a fit.
- Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment
- Ex Vivo Expansion (ACT-X)
- Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology
- Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)
- PumaRx Registry Trial
- Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
- Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
- A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
- Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
- Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
- SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
- Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
- Personalized Models for Cancer Research
- Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
- Immune Profiling for Cancer Immunotherapy Response
- A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
- Cannabis Use and Outcomes in Black and White Patients With Cancer
- The Gut Microbiome and Immunotherapy Response in Solid Cancers
- INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
- Role of Gut Microbiome in Cancer Therapy
- Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
- Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
- XACT ACE Observational Registry
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
- AIMS Cancer Outcomes Study
- Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
- Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- UWCCC Molecular Tumor Board Registry
- Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
- Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
- Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
- Genomic Profiling in Cancer Patients
- Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
- Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
- Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- WellSpan-THRIVE Cancer QOL Study
- A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Biomarkers of Resiliency In Childhood Cancer Surgery
- Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.